Filing Details
- Accession Number:
- 0001415889-25-021441
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-08-11 17:07:18
- Reporting Period:
- 2025-06-17
- Filing Date:
- 2025-08-11
- Accepted Time:
- 2025-08-11 17:07:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1677940 | Beyondspring Inc. | BYSI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1487815 | Xiangmin Cui | C/O Decheng Capital 3000 Sand Hill Road, Bldg. 2, Suite 110 Menlo Park CA 94025 | No | No | Yes | No | |
| 1650291 | Decheng Capital China Life Sciences Usd Fund Ii, L.p. | C/O Decheng Capital 3000 Sand Hill Road, Bldg. 2, Suite 110 Menlo Park CA 94025 | No | No | Yes | No | |
| 1736814 | Decheng Capital China Life Sciences Usd Fund Iii, L.p. | C/O Decheng Capital 3000 Sand Hill Road, Bldg. 2, Suite 110 Menlo Park CA 94025 | No | No | No | No | |
| 1747821 | Decheng Capital Management Iii (Cayman), Llc | C/O Decheng Capital 3000 Sand Hill Road, Bldg. 2, Suite 110 Menlo Park CA 94025 | No | No | Yes | No | |
| 1949026 | Decheng Capital Global Healthcare Fund (Master), Lp | C/O Decheng Capital 3000 Sand Hill Road, Bldg. 2, Suite 110 Menlo Park CA 94025 | No | No | Yes | No | |
| 1949027 | Decheng Capital Global Healthcare Gp, Llc | C/O Decheng Capital 3000 Sand Hill Road, Bldg. 2, Suite 110 Menlo Park CA 94025 | No | No | Yes | No |
Transaction Summary
| Sold: | 394,436 shares | Avg. Price: $3.05 | Total Value: $1,204,042.19 |
| Number of Shares After Transactions: | 891,734 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Disposition | 2025-06-17 | 5,000 | $3.23 | 995,000 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-06-18 | 59,253 | $3.17 | 1,844,326 | No | 4 | S | Indirect | By Decheng Capital China Life Sciences USD Fund II, L.P. |
| Ordinary Shares | Disposition | 2025-06-20 | 60,000 | $3.11 | 935,000 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-06-20 | 225,217 | $3.16 | 1,619,109 | No | 4 | S | Indirect | By Decheng Capital China Life Sciences USD Fund II, L.P. |
| Ordinary Shares | Disposition | 2025-06-23 | 1,700 | $3.09 | 1,617,409 | No | 4 | S | Indirect | By Decheng Capital China Life Sciences USD Fund II, L.P. |
| Ordinary Shares | Disposition | 2025-07-01 | 600 | $2.43 | 934,400 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-07-02 | 324 | $2.42 | 934,076 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-07-08 | 9,059 | $2.29 | 925,017 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-07-09 | 252 | $2.27 | 924,765 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-07-10 | 768 | $2.28 | 923,997 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-07-11 | 246 | $2.29 | 923,751 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-07-14 | 801 | $2.29 | 922,950 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-07-15 | 2,152 | $2.28 | 920,798 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-07-16 | 5,396 | $2.24 | 915,402 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-07-17 | 20,572 | $2.19 | 894,830 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-07-18 | 900 | $2.20 | 893,930 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Ordinary Shares | Disposition | 2025-08-04 | 2,196 | $2.18 | 891,734 | No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital China Life Sciences USD Fund II, L.P. |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital China Life Sciences USD Fund II, L.P. |
| No | 4 | S | Indirect | By Decheng Capital China Life Sciences USD Fund II, L.P. |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
| No | 4 | S | Indirect | By Decheng Capital Global Healthcare Fund (Master), LP |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Ordinary Shares | 1,979,072 | Indirect | By Decheng Capital China Life Sciences USD Fund III, L.P. |
Footnotes
- These securities are held directly by Decheng Capital Global Healthcare Fund (Master), LP ("Healthcare"). Decheng Capital Global Healthcare GP, LLC ("Healthcare GP") is the general partner of Healthcare. Dr. Cui is the manager of Healthcare GP. Each of Healthcare GP and Dr. Cui may be deemed to beneficially own the securities held by Healthcare. Each of Healthcare GP and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.10 to $3.34 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- These securities are held directly by Decheng Capital China Life Sciences USD Fund II, L.P. ("Fund II"). Decheng Capital Management II (Cayman), LLC ("GP II") is the general partner of Fund II. Dr. Cui is the manager of GP II. Each of Fund II, GP II and Dr. Cui may be deemed to beneficially own the securities held by Fund II. Each of GP II and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.05 to $3.27 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $3.06 to $3.19 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of securities sold at each separate price within the range set forth in this footnote.
- These securities are held directly by Decheng Capital China Life Sciences USD Fund III, L.P. ("Fund III"). Decheng Capital Management III (Cayman), LLC ("GP III") is the general partner of Fund III. Dr. Cui is the manager of GP III. Each of Fund III, GP III and Dr. Cui may be deemed to beneficially own the securities held by Fund III. Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.
Billionaire Hedge Funds
